Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Kinase Inhibitors, MAP Kinase Pathway

Roger Davis

PhD

🏢UMass Chan Medical School🌐USA

Howard Hughes Medical Institute Investigator

124
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Roger Davis at UMass Chan Medical School is a pioneer in MAP kinase biology who discovered the JNK (c-Jun N-terminal kinase) stress kinase and has contributed foundational work on the MAPK pathway in cancer. His research has characterized the roles of JNK, p38, and ERK MAP kinase pathways in cancer cell survival and drug resistance. He has contributed to understanding how feedback activation within the MAP kinase pathway limits the efficacy of MEK inhibitors and has studied combination strategies to overcome this feedback. His comprehensive kinase biology research has provided critical insights into therapeutic targeting of the RAS/MAPK network.

Share:

🧪Research Fields 研究领域

JNK MAP kinase signaling cancer
MAP kinase pathway cancer
MEK ERK inhibitor cancer biology
stress kinase cancer biology
RAS MAPK signal transduction

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Roger Davis 的研究动态

Follow Roger Davis's research updates

留下邮箱,当我们发布与 Roger Davis(UMass Chan Medical School)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment